Finance

Lists
SVNS:LON
Solvonis Therapeutics PLC
0,10 GBX
0,00%
(0,00) 1D
16-окт., 16:35:14 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SVNS...
Open
0,10 GBX
High
0,10 GBX
Low
0,10 GBX
Mkt. cap
7,92 млн
Avg. vol.
25,35 млн
Volume
13,32 млн
52-wk high
0,39 GBX
52-wk low
0,10 GBX
EPS
-0,00 GBX
Shares outstanding
7,90 млд
No. of employees
6
Open
0,10 GBX
High
0,10 GBX
Low
0,10 GBX
Mkt. cap
7,92 млн
Avg. vol.
25,35 млн
Volume
13,32 млн
52-wk high
0,39 GBX
52-wk low
0,10 GBX
EPS
-0,00 GBX
Shares outstanding
7,90 млд
No. of employees
6
News stories
From web sources and news partners
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
213,00 миң
213,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
699,50 миң
699,50 миң
505,50 миң
505,50 миң
Operating expense
979,00 миң
979,00 миң
718,50 миң
718,50 миң
Total operating expenses
979,00 миң
979,00 миң
718,50 миң
718,50 миң
Operating income
-979,00 миң
-979,00 миң
-718,50 миң
-718,50 миң
Other non operating income
-
-
-
-
EBT including unusual items
-2,06 млн
-2,06 млн
-718,50 миң
-718,50 миң
EBT excluding unusual items
-928,00 миң
-928,00 миң
-718,50 миң
-718,50 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,06 млн
-2,06 млн
-718,50 миң
-718,50 миң
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,00 миң
2,00 миң
-
-
Interest expense
-
-
-
-
Net interest expenses
2,00 миң
2,00 миң
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору